Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-17

FDA Approved: SIVEXTRO — Supplemental Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved a supplemental application for Sivextro (tedizolid phosphate) from Merck Sharp & Dohme LLC. This action updates the product’s labeling and may incl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sivextro (tedizolid)

Snippet

SUPPL AP for SIVEXTRO (TEDIZOLID PHOSPHATE)